- Home
- ONVO vs AEMD Comparison
ONVO vs AEMD Comparison
Compare ONVO & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONVO
- AEMD
- Stock Information
- Founded
- ONVO 2007
- AEMD 1984
- Country
- ONVO United States
- AEMD United States
- Employees
- ONVO N/A
- AEMD N/A
- Industry
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- AEMD Medical/Dental Instruments
- Sector
- ONVO Health Care
- AEMD Health Care
- Exchange
- ONVO Nasdaq
- AEMD Nasdaq
- Market Cap
- ONVO 7.2M
- AEMD 6.1M
- IPO Year
- ONVO N/A
- AEMD N/A
- Fundamental
- Price
- ONVO $0.42
- AEMD $0.40
- Analyst Decision
- ONVO
- AEMD Strong Buy
- Analyst Count
- ONVO 0
- AEMD 1
- Target Price
- ONVO N/A
- AEMD $7.00
- AVG Volume (30 Days)
- ONVO 102.4K
- AEMD 413.8K
- Earning Date
- ONVO 11-26-2024
- AEMD 11-13-2024
- Dividend Yield
- ONVO N/A
- AEMD N/A
- EPS Growth
- ONVO N/A
- AEMD N/A
- EPS
- ONVO N/A
- AEMD N/A
- Revenue
- ONVO $103,000.00
- AEMD N/A
- Revenue This Year
- ONVO $59.08
- AEMD N/A
- Revenue Next Year
- ONVO $18.24
- AEMD N/A
- P/E Ratio
- ONVO N/A
- AEMD N/A
- Revenue Growth
- ONVO N/A
- AEMD N/A
- 52 Week Low
- ONVO $0.32
- AEMD $0.24
- 52 Week High
- ONVO $1.74
- AEMD $2.35
- Technical
- Relative Strength Index (RSI)
- ONVO 47.62
- AEMD 50.18
- Support Level
- ONVO $0.39
- AEMD $0.38
- Resistance Level
- ONVO $0.46
- AEMD $0.46
- Average True Range (ATR)
- ONVO 0.05
- AEMD 0.03
- MACD
- ONVO -0.00
- AEMD 0.00
- Stochastic Oscillator
- ONVO 62.27
- AEMD 33.15
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.